Fortress Biotech, Inc. (FBIO) Free Cash Flow

Fortress Biotech, Inc. (FBIO) free cash flow history and trends. Track FCF in Excel with MarketXLS.

Free Cash Flow Data

PeriodFree Cash Flow (USD)
2016-12-31-$56.37M
2017-12-31$17.84M
2018-12-31-$263.97M
2019-12-31-$99.71M
2020-12-31-$86.81M
2021-12-31-$132.89M
2022-12-31-$182.46M
2023-12-31-$136.32M
2024-12-31-$95.19M
2025-12-31-$65.78M

How FBIO compares with sector peers

SymbolCompanyFree cash flow (latest fiscal year)
KURAKura Oncology Inc.-$70.70M
AXSMAxsome Therapeutics Inc.-$93.89M
RGNXREGENXBIO Inc.-$126.38M
VSTMVerastem Inc.-$147.13M
ALLOAllogene Therapeutics Inc.-$149.63M

These are five companies in the same sector as FBIO with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.

Get Fortress Biotech, Inc. Data in Excel

Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.

Try: =hf_Free_Cash_Flow("FBIO", 2025, "")

BUY NOW